DYN

Dyne TherapeuticsF

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-18

View Chart

Peers tracked

U.S. public peers

Grade Position

Below peers

vs peer average

DYN vs peer average

21/100

DYN vs. peer average (F vs. C)

Grade spread

A 1 · B 1 · C 4 · D 3 · F 1

Graded peers loaded

Coverage

10 graded

100% of tracked

Peer overview

RGNX is the first available peer comparator.

Regeneron: established protein/oligo pipeline and commercialization experience — useful comparator for late‑stage program commercialization pathways [industry filings].

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerRGNXREGENXBIO

DYN

Dyne Therapeutics

RGNX

REGENXBIO

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Defensive

Constructive

Open Side-by-Side Comparison Compare all

Grade position vs RGNX

DYN / RGNX

Grade Position

Below peers

DYN vs. peer average (F vs. C)

21/100

Momentum

RGNX

Value

DYN

Sentiment

RGNX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs DYN

RGNX

100/100

-4

NTLA

60/100

-2

CPRX

Catalyst Pharmaceuticals Inc Common

60/100

-2

ELVN

Enliven Therapeutics Inc Common

40/100

-1

LEGN

Legend Biotech Corp ADR

40/100

-1

RGNX is the first peer returned for this comparison set.